NCT Number: NCT02714582
Hospitals face the challenge to continually improve their quality of care. In order to achieve this goal, they have to focus on both improving clinical practice and increasing the involvement of patients in the healthcare process. Both factors are equally important to quality of care. The World Health Organization highlights the role that patients and their family could play in the improvement of healthcare. Active patient participation reduces communication errors, increases patient empowerment and is associated with positive health and psychosocial outcomes. A possible strategy to improve patient participation through communication can be bedside shift report (BSR).
Bedside shift report is a process where shift-to-shift report between nurses is, if approved by the patient, executed at the patient's bedside in order to improve the patient's involvement. Bedside shift report has the potential to result in more patient satisfaction, better clinical outcomes, improvement of health education and enhanced team coherence. Preliminary research indicates that BSR decreases safety incidents and adverse events and readmissions, positively influences staff satisfaction, offers beneficial financial effects by reducing nurses' overtime, and allows direct patient care to start earlier.
Despite of these effects, rigorous and large-scale scientific research on this topic is lacking. Currently, the available evidence is scarce and mostly consists of single case or small-scale studies. Longitudinal results on effectiveness and sustainability of BSR are also unknown or inconclusive. There is a need for an increased number of controlled studies to evaluate the impact of BSR on patient, staff and economic outcomes and its longitudinal results.
The aim of this study is four-folded:
1. The development and fine-tuning of a BSR-intervention and implementation protocol by using diagnostic interviews, co-design, and pilot studies. 2. A quantitative evaluation of BSR in comparison with care as usual on patient-related, clinical, and nurse-related outcomes. 3. A qualitative evaluation of the feasibility, appropriateness and meaningfulness of BSR as a method to improve communication and patient participation with a particular interest in the experience of benefits and disadvantages by healthcare professionals and patients. 4. A process evaluation of BSR to determine the intervention fidelity and to assess the evolution of BSR over the period of the study (e.g. adaptations, consistent practice).
The study design was based on the Medical Research Council-framework for developing and evaluating complex interventions. Power calculation indicates a minimum of 5 experimental wards with 35 patients should be included in the study. The hospital, the specialization of the ward and the nurse-patient ratio will be used for the matched controlled assignment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
AZ Sint-Jan, Bruges, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patients
Inclusion criteria
Exclusion criteria
Nurses
Inclusion criteria
Exclusion criteria
Bedside shift report is a process where shift-to-shift report between nurses is, if approved by the patient, executed at the patient's bedside in order to improve the patient's involvement (Anderson & Mangino 2006).
Other names: Bedside shift handover
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in Patient Empowerment during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.
The data will be collected by use of a questionnaire for patients. A validated tool, the Patient Activation Measure (PAM13), will be used.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in Quality of Care during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.
The data will be collected by use of a questionnaire for patients. A validated tool, the QPP (Quality of care from the Patient's Perspective), will be used.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in Individualized Care during the study will be investigated by use of repeated measures. For patients, the patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.
The data will be collected by use of a questionnaire for patients. A validated tool, the ICS (Individualized Care Scale), will be used.
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Individualized Care during the study will be investigated by use of repeated measures. For nurses, the patterns of change between baseline and 24 months will be evaluated.
The data will be collected by use of a questionnaire for nurses. A validated tool, the ICS (Individualized Care Scale), will be used.
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Job Satisfaction during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.
The data will be collected by use of a questionnaire for nurses. A validated tool, the MOAQ-JSS (Michigan Organizational Assessment Questionnaire - Job Satisfaction Subscale), will be used.
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Turnover Intention during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.
The data will be collected by use of a questionnaire for nurses. A validated tool, the MOAQ-TIS (Michigan Organizational Assessment Questionnaire - Turnover Intention Subscale), will be used.
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Turnover Intention during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.
The data will be collected by use of a questionnaire for nurses. Two questions from the RN4CAST (Nurse Forecasting: Human Resources Planning in Nursing) are used.
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Coordination of the Care Process during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.
The data will be collected by use of a questionnaire for nurses. A validated tool, the CPSET-COR (Care Process Self Evaluation Tool - Coordination subscale), will be used.
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Communication during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.
The data will be collected by use of a questionnaire for nurses. A validated tool, the CPSET-COM (Care Process Self Evaluation Tool - Communication subscale), will be used.
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Work Interruptions during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.
The data will be collected by use of a questionnaire for nurses. A non-validated tool to measure nurses' perceptions on work interruptions, developed by the researchers, will be used.
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Work Interruptions during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated..
The data will be collected from electronic databases from within the participating hospitals that measure the number of work interruptions ('calls for assistance').
Time frame: 24 months: 2 data collections during the study (baseline, 24 months)
The change in Patient Participation during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.
The data will be collected by use of a questionnaire for nurses. Five questions from a validated tool, the PaCT-HCW (Patient Participation Culture Tool for Healthcare Workers), will be used.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in incidence of HAPU's during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.
The data will be collected from the patient's medical file. The timeframe for registration is from the admission on the ward until discharge from the ward. Any HAPU's during the patient's stay on the ward on heel and sacrum will registered by use of the NPUAP/EPUAP classification system.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in incidence of Patient Falls during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.
The data will be collected from the patient's medical file. The timeframe for registration is admission on the ward until discharge from the ward. Any patient falls during the patient's stay on the ward will registered.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in incidence of Unnecessary New Intravenous Drips during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.
The data will be collected from the patient's medical file. The timeframe for registration is from admission on the ward until discharge from the ward with a maximum of 30 days. Newly placed intravenous drips without explicit physician indication will be registered.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in Length of Stay during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.
The data will be collected from the patient's medical file. The total length of stay on the ward will be registered.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in incidence of Unplanned Readmissions during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.
The data will be collected from the patient's medical file. Readmissions within 30 days in the same hospital will be registered.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in Pain scores during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, 24 months will be evaluated.
The data will be collected from the patient's medical file. The timeframe for registration is from admission on the ward until discharge from the ward. The first pain score after the nurse shift report will be registered each day.
Time frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
The change in the Duration of the Shift Report during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months,18 months, and 24 months will be evaluated.
Thirteen shift reports will be recorded during each data collection point. Based on the recordings, the duration of the shift report will be calculated.
Time frame: 12 months: 1 data collection (12 months)
The data concerning the experienced Feasibility of BSR will be collected by use of individual, semi-structured interviews (patients) and semi-structured focus group interviews (nurses) using an interview guide. The data will be collected at 12 months.
Time frame: 12 months: 1 data collection (12 months)
The data concerning the experienced Applicability of BSR will be collected by use of individual, semi-structured interviews (patients) and semi-structured focus group interviews (nurses) using an interview guide. The data will be collected at 12 months.
Time frame: 12 months: 1 data collection (12 months)
The data concerning the experienced Meaningfulness of BSR will be collected by use of individual, semi-structured interviews (patients) and semi-structured focus group interviews (nurses) using an interview guide. The data will be collected at 12 months.
Time frame: 24 months: 2 data collections during the study(between 12 months and 18 months; between 18 months and 24 months)
The change in Intervention Fidelity during the study will be investigated by use of repeated measures. The patterns of change will be evaluated.
The data will be collected by use of non-participating observations. A checklist will be used. During each period (12 months until 18 months / 18 months until 24 months) 20 non-participating observations on each ward will be performed.
University Hospital, Ghent
Other
Patient Participation at the Bedside: Feasibility, Appropriateness, Meaningfulness and Effectiveness of Bedside Shift Reporting. A Matched Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06905119
Administration, Intravenous, Adverse Effects
Pamplona, Navarre, Spain
View Trial DetailsNCT06753799
Behavior, Cardiovascular Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05902156
Behavior, Decision Support System
Antalya, Turkey (Türkiye)
View Trial DetailsNCT07730411
Education, Nursing
Malatya, Turkey (Türkiye)
View Trial Details